Standout Papers

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer 2015 2026 2018 2022 1.8k
  1. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer (2015)
    Christopher J. Sweeney, Yu‐Hui Chen et al. New England Journal of Medicine
  2. Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial (2018)
    Christos E. Kyriakopoulos, Yu‐Hui Chen et al. Journal of Clinical Oncology

Immediate Impact

8 from Science/Nature 66 standout
Sub-graph 1 of 20

Citing Papers

Macrophages at the interface of the co-evolving cancer ecosystem
2023 Standout
Improved Outcomes with Enzalutamide in Biochemically Recurrent Prostate Cancer
2023 Standout
28 intermediate papers

Works of Daniel H. Shevrin being referenced

Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer: Long-Term Survival Analysis of the Randomized Phase III E3805 CHAARTED Trial
2018 Standout
Chemohormonal Therapy in Metastatic Hormone-Sensitive Prostate Cancer
2015 Standout
and 5 more

Author Peers

Author Last Decade Papers Cites
Daniel H. Shevrin 2997 1164 1154 77 3.8k
Susan Feyerabend 3080 977 974 71 3.7k
Peter De Porre 2399 734 863 90 3.3k
Matthew M. Cooney 3474 1773 1103 85 5.0k
Mary B. Todd 2081 589 721 54 2.5k
Steinbjørn Hansen 3036 1700 1311 88 5.5k
Nancy A. Dawson 2510 1309 563 143 4.2k
A. Rodrı́guez-Antolı́n 2423 613 759 141 3.1k
Jean-Pascal Machiels 2365 1999 1004 36 4.4k
David Lorente 1806 1147 643 100 2.8k
Matthew R. Smith 3274 2873 1366 69 5.3k

All Works

Loading papers...

Rankless by CCL
2026